Phone Number: 617-428-5150
Mr. Capone is an accomplished, global Biotech and Pharma leader with a 20+ year track record of accelerating breakthrough science, drug development and commercialization. Currently he is CBO of GeneCentric Therapeutics where he is spearheading genomic-driven cancer drug development. From 2010-2016, Mr. Capone was CEO & President of the Multiple Myeloma Research Foundation (MMRF) and the Multiple Myeloma Research Consortium (MMRC), where he transformed the Foundation to leverage industry experience, academic research and FDA collaborations. In his roles as SVP Commercial Operations, VP Commercial Development, and Division Manager for Progenics, Triangle Pharmaceuticals, Trimeris, BMS, Wyeth and Lederle, Mr. Capone has led the development and launch of over 18 novel drugs including FUZEON®, EMTRIVA®, TEQUIN®, ZERIT®, VIDEX®, and ZOSYN®. He obtained his M.B.A. from Columbia University and B.A. from Brown University.